Coherus BioSciences (NASDAQ:CHRS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Coherus BioSciences (CHRS) operate in?

Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.

Open	$1.41
Close	-
Volume / Avg.	586.37K / 1.68M
Day Range	1.34 - 1.41
52 Wk Range	1.37 - 5.47
Market Cap	$156.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	22.6%
Days to Cover	17.69

Recent News

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2. CommScope shares dipped 6.9% to $2.2150 on Monday.

Avi Kapoor

Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?

Coherus BioSciences agreed to sell its ophthalmology franchise for $170M to Sandoz. This aligns with CHRS' focus on oncology and will help reduce debt and overhead costs.

Vandana Singh

Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Coherus Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Coherus BioSciences (CHRS) stock?

You can purchase shares of Coherus BioSciences (NASDAQ:CHRS) through any online brokerage.

View our list of the best stock brokerages

Who are Coherus BioSciences (CHRS) competitors?

Other companies in Coherus BioSciences’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).

What is the target price for Coherus BioSciences (CHRS) stock?

There is no analysis for Coherus BioSciences.

What is the forecast for Coherus BioSciences (CHRS) stock?

Coherus BioSciences has a consensus price target of $9.89.

Current stock price for Coherus BioSciences (CHRS)?

The stock price for Coherus BioSciences (NASDAQ: CHRS) is $1.36 last updated Today at July 3, 2024 at 10:05 AM EDT.

Does Coherus BioSciences (CHRS) pay a dividend?

There are no upcoming dividends for Coherus BioSciences.

When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?

Coherus BioSciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is Coherus BioSciences (CHRS) going to split?

There is no upcoming split for Coherus BioSciences.

What sector and industry does Coherus BioSciences (CHRS) operate in?

Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Coherus BioSciences

Coherus BioSciences (CHRS) Forecast